Risperdal manufacturers docked

Risperdal Manufacturers Docked Again For Failure-to-Warn

A trial in the Philadelphia Court of Common Pleas reached another verdict on a case concerning Johnson & Johnson’s drug Risperdal on Friday, March 20, ruling that while the company failed to adequately warn about a major side effect, it would not award damages to plaintiff William Cirba.